Published in Biomed Res Int on June 04, 2015
Caffeine as an opioid analgesic adjuvant in fibromyalgia. J Pain Res (2017) 0.75
Ethical guidelines for investigations of experimental pain in conscious animals. Pain (1983) 17.70
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev (2006) 15.09
Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev (1999) 6.26
Chronic catheterization of the spinal subarachnoid space. Physiol Behav (1976) 6.16
Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. J Pharmacol Exp Ther (1992) 3.58
Tramadol: a new centrally acting analgesic. Am J Health Syst Pharm (1997) 1.88
Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol. J Pharmacol Exp Ther (1993) 1.71
Spinal cord mechanisms of pain. Br J Anaesth (2008) 1.41
The neuronal 5-HT3 receptor network after 20 years of research--evolving concepts in management of pain and inflammation. Eur J Pharmacol (2007) 1.35
Standardization of the rat paw formalin test for the evaluation of analgesics. Psychopharmacology (Berl) (1991) 1.31
Differential mediation of descending pain facilitation and inhibition by spinal 5HT-3 and 5HT-7 receptors. Brain Res (2009) 1.22
Metabotropic receptors for glutamate and GABA in pain. Brain Res Rev (2008) 1.20
Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action. Pharmacol Rev (1993) 1.16
Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry implications for drug addiction, sleep and pain. Prog Neurobiol (2007) 1.10
Descending control of pain. Br J Anaesth (1995) 1.09
Serotonin receptor subtypes involved in the spinal antinociceptive effect of 5-HT in rats. Pain (2000) 1.07
Possible mechanisms of morphine analgesia. Clin Neuropharmacol (1991) 1.02
Actions of tramadol, its enantiomers and principal metabolite, O-desmethyltramadol, on serotonin (5-HT) efflux and uptake in the rat dorsal raphe nucleus. Br J Anaesth (1997) 0.99
Effects of 5-HT2 and 5-HT3 receptors on the modulation of nociceptive transmission in rat spinal cord according to the formalin test. Eur J Pharmacol (2001) 0.98
Electrophysiological properties of cultured neonatal rat dorsal horn neurons containing GABA and met-enkephalin-like immunoreactivity. J Neurophysiol (1998) 0.97
The antinociceptive effect of tramadol in the formalin test is mediated by the serotonergic component. Eur J Pharmacol (2002) 0.94
Antinociception, tolerance, and physical dependence comparison between morphine and tramadol. Pharmacol Biochem Behav (1998) 0.94
Ondansetron inhibits the analgesic effects of tramadol: a possible 5-HT(3) spinal receptor involvement in acute pain in humans. Anesth Analg (2002) 0.93
Facilitatory actions of serotonin type 3 receptors on GABAergic inhibitory synaptic transmission in the spinal superficial dorsal horn. J Neurophysiol (2009) 0.93
Tramadol and caffeine produce synergistic interactions on antinociception measured in a formalin model. Pharmacol Biochem Behav (2010) 0.93
Methylxanthines and pain. Handb Exp Pharmacol (2011) 0.91
Transmitter content, origins and connections of axons in the spinal cord that possess the serotonin (5-hydroxytryptamine) 3 receptor. Neuroscience (2005) 0.91
Spinal 5-HT7 receptors play an important role in the antinociceptive and antihyperalgesic effects of tramadol and its metabolite, O-Desmethyltramadol, via activation of descending serotonergic pathways. Anesthesiology (2010) 0.90
Differential effects of adenosine receptor antagonists injected intrathecally on antinociception induced by morphine and beta-endorphin administered intracerebroventricularly in the mouse. Neuropeptides (1997) 0.87
Enhancement of antinociception by co-administration of ibuprofen and caffeine in arthritic rats. Eur J Pharmacol (2006) 0.86
The activation of 5-HT(3) receptors evokes GABA release in the spinal cord. Brain Res (2003) 0.84
Spinal adenosine modulates descending antinociceptive pathways stimulated by morphine. J Pharmacol Exp Ther (1986) 0.84
5-HT(3A) receptor subunit is expressed in a subpopulation of GABAergic and enkephalinergic neurons in the mouse dorsal spinal cord. Neurosci Lett (2008) 0.84
Caffeine injection raises brain tryptophan level, but does not stimulate the rate of serotonin synthesis in rat brain. Life Sci (1984) 0.84
Input-specific modulation of neurotransmitter release in the lateral horn of the spinal cord via adenosine receptors. J Neurosci (2004) 0.84
Tramadol increases extracellular levels of serotonin and noradrenaline as measured by in vivo microdialysis in the ventral hippocampus of freely-moving rats. Neurosci Lett (2010) 0.83
Caffeine antinociception in the rat hot-plate and formalin tests and locomotor stimulation: involvement of noradrenergic mechanisms. Pain (1995) 0.82
Effect of caffeine on ibuprofen analgesia in postoperative oral surgery pain. Clin Pharmacol Ther (1991) 0.82
Involvement of serotonin 2A receptors in the analgesic effect of tramadol in mono-arthritic rats. Brain Res (2008) 0.82
Effect of caffeine on antinociceptive action of ketoprofen in rats. Arch Med Res (2001) 0.79
Morphine--caffeine analgesic interaction in rats. Anesth Analg (1985) 0.78
Formalin-induced pain and mu-opioid receptor density in brain and spinal cord are modulated by A1 and A2a adenosine agonists in mice. Brain Res (2002) 0.78
Spinal and peripheral adenosine A₁ receptors contribute to antinociception by tramadol in the formalin test in mice. Eur J Pharmacol (2013) 0.77
Adjuvant effect of caffeine on acetylsalicylic acid anti-nociception: prostaglandin E2 synthesis determination in carrageenan-induced peripheral inflammation in rat. Eur J Pain (2007) 0.77
Gender-related differences in pharmacokinetics of enantiomers of trans-tramadol and its active metabolite, trans-O-demethyltramadol, in rats. Acta Pharmacol Sin (2003) 0.77
The effect of methylxanthines on morphine analgesia in mice and rats. Pol J Pharmacol Pharm (1989) 0.76
Neurotoxin-induced lesions to central serotonergic, noradrenergic and dopaminergic systems modify caffeine-induced antinociception in the formalin test and locomotor stimulation in rats. J Pharmacol Exp Ther (1996) 0.76
Potentiation of morphine analgesia by caffeine. Br J Pharmacol (1985) 0.76